Navigation Links
RESPONSE to the FDA and Public Health Experts Findings on Electronic Cigarettes
Date:7/23/2009

LOS ANGELES, July 23 /PRNewswire/ -- Yesterday, the FDA announced that after laboratory analysis of electronic cigarette samples they have discovered that Electronic Cigarettes contain carcinogens and toxic chemicals. However, this does not ring true for U.S. based manufacturer, SmokeStik, LTD. The FDA report analyzed e-cigarettes cartridges and listed several compounds of concern, such as, Diethylene Glycol, Tobacco specific nitrosamines, Anabasine, and Myosmine. Independent lab results have shown that none of these compounds are present in SmokeStik products.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090723/LA51264)

SmokeStik has released the following statement:

"As a company that is categorized in the 'e-cigarette' industry, SmokeStik is both aware and concerned about the FDA's findings released yesterday regarding electronic cigarettes. While we cannot speak specifically to the components of NJOY or Smoking Everywhere's cartridges, we do understand from public sources that these cartridges are imported from China. As many of our distributors are aware, as of last month, SmokeStik's cartridges are now made domestically. Moreover, all of the ingredients in SmokeStik's cartridges are certified by independent laboratories and most importantly; do NOT contain any of the carcinogens referenced in the Final Report on FDA Analyses.

SmokeStik has always presented its products as an 'alternative' for responsible, adult smokers, and not as a smoking cessation product. SmokeStik has NEVER sold flavored cartridges such as those referenced in the FDA's Report. As a company, we oppose this type of marketing and discourage teenagers from using our products."

If you would like to speak with SmokeStik, please contact Alexis Wallsh at Entertainment Fusion Group, alexis@efgpr.com or 310.432.0020.

About SmokeStik, LTD

SmokeStik, LTD is a U.S.-based manufacturer of the alternative smoking device, SmokeStik. SmokeStik effectively replicates the smoking experience while eliminating carcinogens, secondhand smoke, odor and litter. SmokeStik poses no health risks, thereby contributing to the reduction of the leading cause of preventable death in America - tobacco; SmokeStik is available in the U.S., the EU and South America. For more information, please visit www.SmokeStik.com.


'/>"/>
SOURCE SmokeStik, LTD
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cell division find prompts overhaul of immune response modeling
2. Labopharm receives complete response letter from the U.S. FDA for novel antidepressant
3. Camp High Harbour Response to Flu Outbreak Includes SpectraSan 24 Disinfectant
4. CIFOR Guidelines for Foodborne Disease Outbreak Response Published by National Food Safety Group
5. Emdeon To Collaborate With Rx Response in Critical Pharmacy Disaster Reporting
6. Accumetrics VerifyNow(R) P2Y12 Test Provides Physicians With Information to Assess a Patients Response to Newly-Approved Prasugrel (Effient(R))
7. Watson Pharmaceuticals Receives a Complete Response Letter for Its 24-Week Formulation of TRELSTAR(R) (triptorelin pamoate) NDA from US FDA
8. Immucor Submits 10-Day Response to FDA; Establishes Product Surveillance and Improvement Department
9. Immune Response May Speed AIDS Progression in Women
10. Statement by Jim OHara, Director, Produce Safety Project, in Response to the White House Announcement on the Proposed FDA Rule on Produce Safety
11. Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... and relationship-marketing firm, announced today that nominations will be accepted from December ... (ISE®) Central Awards. , Awards include the Information Security Executive® of the ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Meeting through tomorrow, December 6th, sparks a conversation about epilepsy, bearing down on ... in 26 people will be diagnosed with epilepsy within their lifetime. With such ...
(Date:12/5/2016)... , ... December 05, 2016 ... ... interoperability, today announced that the company will provide alerting technology to Central ... been recently awarded $1.7 million in federal funds as the sole sub-recipient ...
(Date:12/5/2016)... ... December 05, 2016 , ... Dr. Barry M. Weintraub, one ... Surgery, who recently participated in the 36th Annual Cutting Edge Aesthetic Symposium at the ... techniques for getting that perfect, yet natural-looking, nose. Dr. Weintraub, who is world-renowned for ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... Officer for the Florida Hospital West Florida Region. McGuinness brings experience in executive ... and engaging staff, physicians and leaders. , In her new role, that officially ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec. 5, 2016  BD (Becton, Dickinson ... global medical technology company, will demonstrate an enhanced technology ... management technologies, including the company,s leading Pyxis™ and Alaris™ ... Pharmacists (ASHP) 2016 Midyear Meeting being held in ... While national data show that approximately 68 ...
(Date:12/5/2016)... Research and Markets has announced the addition of the "Global ... and Demand Forecast to 2022" report to their offering. ... , , ... market is expected to grow at a CAGR of 4.5% during ... witnessing high growth, due to growing female geriatric population and increasing ...
(Date:12/5/2016)... England , December 5, 2016 ... Transitions to Deputy Chairman   ... on selectively targeting deubiquitylating enzymes (DUBs) to treat cancer, neurodegenerative ... has been appointed as non-executive Chairman, effective January 1 st ... of Mission Therapeutics as a non-executive Director in July 2015. ...
Breaking Medicine Technology: